BioVie Inc. Notes Payable
BioVie Inc. (BIVI) had Notes Payable of $2.50 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:NotesPayable · last filed 2024-11-13
- 2024-09-30: Notes Payable $2.50M.
- 2024-06-30: Notes Payable $5.00M.
- 2022-12-31: Notes Payable $15.00M.
- 2022-09-30: Notes Payable $15.00M.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2024-09-30 | $2.50M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $5.00M 10-K · filed 2024-09-30 | |
| 2022-12-31 | $15.00M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $15.00M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $15.00M 10-Q · filed 2023-02-10 | |
| 2022-03-31 | $11.60M 10-Q · filed 2023-05-12 | $15.00M 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |